Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» izencitinib
izencitinib
Theravance takes a gut punch as J&J-partnered JAK drug flops key test in ulcerative colitis
Endpoints
Mon, 08/23/21 - 11:26 pm
Theravance
izencitinib
ulcerative colitis
Crohn’s disease
clinical trials